A Look At Mirion Technologies (MIR) Valuation After Mixed Recent Share Price Performance

Mirion Technologies (MIR) trades around $19.27, putting its recent performance in focus after a mixed pattern of returns, with gains over the past year along with a decline over the past 3 months.

See our latest analysis for Mirion Technologies.

The recent 30 day share price return of 3.10% contrasts with a 27.39% decline over 90 days, while the 1 year total shareholder return of 40.55% indicates that longer term momentum remains positive.

If this kind of moves in radiation and nuclear related names has your attention, it could be a good moment to check out 93 nuclear energy infrastructure stocks

With Mirion posting revenue of US$925.4m, net income of US$28.8m and trading at US$19.27 against an analyst price target of US$28.10, is the market underestimating its future potential or already pricing in what comes next?

Most Popular Narrative: 31.4% Undervalued

With Mirion's fair value in the widely followed narrative set at $28.10 against a last close of $19.27, the story hinges on whether growth and margins can support that gap.

Continued rollout of new digital platforms, such as the Vital and Apex-Guard software, along with the Certrec acquisition, positions Mirion to capture premium pricing, drive software mix expansion, and unlock operating leverage, benefitting margins and long-term earnings potential. Recent investment in capital structure optimization has reduced interest expense and increased financial flexibility, enabling additional M&A and technology investments while freeing up cash flow that may be deployed to accretive growth initiatives or returned to shareholders, improving net margin and cash generation over time.

Read the complete narrative.

Curious what kind of revenue runway and margin lift need to line up for that valuation gap to make sense? The narrative leans on fast compounding earnings, a richer mix of higher value software and services, and a future earnings multiple that assumes Mirion keeps justifying a premium story.

Result: Fair Value of $28.10 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, that upside story can unwind quickly if nuclear sector spending slows, or if acquisitions like Certrec fail to deliver the expected margin and earnings support.

Find out about the key risks to this Mirion Technologies narrative.

Another View: Market Multiple Sends a Different Signal

While the narrative fair value of $28.10 suggests Mirion looks 31.4% undervalued versus $19.27, the current P/S of 5.1x tells a tougher story. That is richer than the US Electronic industry at 2.5x, peers at 3.7x, and an estimated fair ratio of 3.5x, which points to valuation risk if sentiment cools.

With one framework pointing to potential upside and another hinting at a premium price tag, investors may consider which signal to prioritize when thinking about position size and timing in Mirion. See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

The mix of upside potential and clear risks here is hard to ignore, so consider reviewing the key figures yourself and weighing both sides with the 3 key rewards and 3 important warning signs

Ready to hunt for more ideas?

If Mirion has you thinking about what else could be worth your attention, do not stop here, broaden your watchlist with a few focused screens.

• Target dependable income by reviewing companies that show up in the 11 dividend fortresses and see which payouts might fit your goals.
• Spot potential value opportunities by scanning the 58 high quality undervalued stocks and compare how their fundamentals line up with prices on the screen.
• Prioritize resilience by checking companies highlighted in the 72 resilient stocks with low risk scores and see which ones match your comfort with risk.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com